Canada’s women’s health leaders turn strategy into impact at the 2026 Femtech Canada Forum in Toronto

The third annual Femtech Canada Forum brought 150+ leaders from research, clinical care, government, industry and investment to Toronto to work through the data, procurement and policy barriers slowing women's health innovation. Femtech Canada also announced the Femtech Toolbox, an employer platform launching in late November.
Group of women leaders standing together on stage at the 2026 Femtech Forum, with the Femtech Canada logo overlaid.

Canadian Femtech in the news

Recent News

Thomas Cortina and Marina Pavlovic Rivas of Eli Health

Eli Health Raises $3.6 Million To Improve Women’s Health With Saliva-Based Continuous Hormone-Monitoring Technology

Hormone fluctuations affect a broad range of conditions, transitions, and symptoms experienced by women from puberty to post-menopause. These fluctuations impact not only menstrual cycles but also various aspects of women’s physical and mental health. Apart from being related to reproductive health – menopause, fertility, and contraception, hormones are behind endocrine conditions, which

Read More »
Banner image of 2022 Women of the Year

Women of the Year 2022: Canada’s Most Incredible Women Leaders

It’s back! Our second annual celebration of Canada’s most inspiring women is here. From tech startup founders and social impact heroes to entrepreneurial leaders and transformational pioneers, meet 25 incredible individuals who are changing the game and leading Canada forward. Read the original article. A special congratulations to two members

Read More »
A woman identifying individual in a blue knitted shirt sitting on a chair holding their stomach in pain

The Rise of Femtech

A boom in technology for women is good for everyone. In 2014, Apple released its first Health app to much fanfare. It was designed to help people monitor things like weight, height, and sodium intake: “all of your metrics that you’re most interested in,” Apple exec Craig Federighi told The Verge at the

Read More »
The Prospects Oncology Fund, HDAX Therapeutics and Hyivy Health logos

Facit’s Prospects Fund Fuels Women’s Health and Brain Cancer Therapies for Ontario Patients

Seed-stage commercialization realizes value in the Province’s health research and intellectual property. September 28, 2022 – FACIT congratulates Ontario-based start-ups Hyivy Health and HDAX Therapeutics as the latest recipients of capital through its Prospects Oncology Fund. Selected among a top-tier pool of applicants, these Ontario-based innovations illustrate excellent potential to

Read More »

Innovator Spotlights

View Older Posts
View All Categories